The medical use of cannabis is an evolving field with limitations on the amount and quality of research currently available to support its use.
Featuring Dr. Michael Allan, lead author of the 2018 Simplified Guideline for Prescribing Medical Cannabinoids in Primary Care. Created in partnership by the OMA and the College of Family Physicians of Canada.
Cannabis may not be suitable for some special risk populations, including:
For a detailed overview of the risks of cannabis use in the populations listed above and links to position statements from the relevant medical societies visit our Cannabis and Special Risk Populations page.
Cannabis is composed of hundreds of chemical compounds including cannabinoids (like THC and CBD), terpenes, flavonoids, and others.
Lecture series created in partnership by the OMA and the Michael G. DeGroote Centre for Medicinal Cannabis Research.
Updated: October 12, 2018